Cyclophosphamide Versus Leflunomide Combined with Prednisone Respectively in Treatment of Chronic Progressive IgA Nephropathy
Zou Yuron
Abstract
Zou Yuron
Abstract
Objective:To compare the efficacy and safety of cyclophosphamide( CTX) or leflunomide( LEF) combined with prednisone respectively in treatment of chronic progressive IgA nephropathy( IgAN).Methods:A retrospective analysis about 57 IgAN patients from June 2009 to July 2012,which were Lee's grade Ⅱ or above,and treated with CTX( 25cases) or LEF( 32cases) combined to prednisone respectively,clinical datas were collected before treatment and during monthly follow-up.Results:The overall 24h urine protein remission rate of the two groups was 87.7%,The partial remission rate of CTX group and LEF group were7 cases( 28.0%) and 11 cases( 34.4%) respectively( P = 0.607),complete remission rate of that were 14 cases( 56.0%) and 18( 56.2%) respectively( P =0.985).CTX group and LEF group partial remission time was( 2.95 ±1.70) month and( 3.27 ± 3.01) month respectively,the difference was statistically significant( P = 0.048),the complete remission time was( 5.45 ± 3.31) month and( 6.69 ± 5.82) month( P = 0.052).During follow-up,there was 12.0% incidence of side effects in CTX group and 6.25% in LEF group.Conclusion:The treatment with CTX or LEF combined prednisone in chronic progressive IgAN has the same effect,Partial remission time in CTX group is faster than that in LEF group,the long-term efficacy and safety remains to be clarified.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To compare the efficacy and safety of cyclophosphamide( CTX) or leflunomide( LEF) combined with prednisone respectively in treatment of chronic progressive IgA nephropathy( IgAN).Methods:A retrospective analysis about 57 IgAN patients from June 2009 to July 2012,which were Lee's grade Ⅱ or above,and treated with CTX( 25cases) or LEF( 32cases) combined to prednisone respectively,clinical datas were collected before treatment and during monthly follow-up.Results:The overall 24h urine protein remission rate of the two groups was 87.7%,The partial remission rate of CTX group and LEF group were7 cases( 28.0%) and 11 cases( 34.4%) respectively( P = 0.607),complete remission rate of that were 14 cases( 56.0%) and 18( 56.2%) respectively( P =0.985).CTX group and LEF group partial remission time was( 2.95 ±1.70) month and( 3.27 ± 3.01) month respectively,the difference was statistically significant( P = 0.048),the complete remission time was( 5.45 ± 3.31) month and( 6.69 ± 5.82) month( P = 0.052).During follow-up,there was 12.0% incidence of side effects in CTX group and 6.25% in LEF group.Conclusion:The treatment with CTX or LEF combined prednisone in chronic progressive IgAN has the same effect,Partial remission time in CTX group is faster than that in LEF group,the long-term efficacy and safety remains to be clarified.
Key concepts: Medicine, Prednisone, Cyclophosphamide, Leflunomide, Gastroenterology, Internal medicine, Incidence (geometry), Complete remission